Join us in celebrating and honoring the up-and-coming leaders who are vital to the future of the pharmaceutical and biotech industry.
In order to nominate yourself or someone you think is an Emerging Pharma Leader, first consider the qualities, knowledge, skills, and activities of the nominee. Are they headed for the C-Suite? Do they have what it takes to make the tough decisions that will continue to face manufacturers in the coming years? Can they navigate the commercial, financial, scientific, R&D, marketing, sales, and/or market access with leadership and inspiration? Do they have what it takes to get to the next level?
To review the accomplishments of 2021 winners, read here.
**Deadline now extended to February, 28, 2022 at 11:59 pm EST.**
If you have any questions on the entry process, please contact the organizers by email here.
For the official press release from MJH Life Sciences on the 2022 Emerging Pharma Leaders Awards, click here.
To sign up and submit a nomination, click here.
FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections
February 11th 2025Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be approved by the FDA for complicated intra-abdominal infections with limited treatment options.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.